United States · FDA National Drug Code directory
PANTOPRAZOLE SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-225_555e2b8d-1265-9a7b-e063-6294a90a0ff4
- Product NDC
- 85766-225
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- PANTOPRAZOLE
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140910
- Source listing expiry
- 20271231
Source-listed ingredients
- PANTOPRAZOLE SODIUM — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-01) · 85766-225-01
- 7 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-07) · 85766-225-07
- 10 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-10) · 85766-225-10
- 14 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-14) · 85766-225-14
- 20 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-20) · 85766-225-20
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-30) · 85766-225-30
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-60) · 85766-225-60
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (85766-225-90) · 85766-225-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →